Alzheimer’s disease and the urgent need for more effective treatments have been making headlines this year, with the FDA approving limited use of a new drug for the first time in nearly two decades. We recently sat down with Lon Schneider, MD, Della Martin chair in psychiatry and neuroscience at the Keck School of Medicine of USC and the director of the California Alzheimer’s Disease Center at USC, to discuss the role of medication in Alzheimer’s treatment.
Q: What are currently the best ways to medically manage the disease?
A: It’s a complicated question. There’s a saying you hear in the field: “If you’ve seen one person with…
